The GrowHub Limited Overview
The GrowHub Limited is a Singapore-based, Cayman-domiciled holding company that has marketed itself as a blockchain-enabled supply-chain traceability provider. It focuses on food and agricultural products in Asia-Pacific. Its proprietary GrowHub Platform runs on the public Polygon blockchain and bundles three functions: product traceability via QR/NFC consumer interfaces, anti-counterfeit authentication, and carbon tracking. Alongside it sit a small product-trading facilitation business and project-based IT professional services. Commercial traction has been minimal: revenue peaked at S$237k in FY2024 and fell to S$83k in FY2025. The FY2025 net loss of S$17.2M was driven overwhelmingly by S$12.9M of professional fees following a US$15M Nasdaq IPO in August 2025. By mid-2026 the company had a shareholders' deficit, faced Nasdaq delisting proceedings, and had signed a US$400M-valuation reverse merger with EnChem America. That deal would hand about 85% of the company to the battery-electrolyte maker and effectively repurpose the listing as a U.S. battery-materials vehicle.
Company's own description (paraphrased from FY2025 20-F and 424B4)
In its FY2025 annual report, the company describes itself as an investment holding company. Through its subsidiaries it provides product traceability, data analytics and product-trading facilitation, with an emphasis on authenticity and sustainability in the food supply chain. It identifies two divisions:
-
GrowHub Platform: a blockchain-based service hosted on the Polygon network. It offers traceability, anti-counterfeit and carbon-management tools.
-
Product trading facilitation: placing partner products into retail and online channels.
The IPO materials (2025) frame a vision of letting the world "consume with confidence." They described a third division, the GrowHub Innovation Centre in Western Australia, expected to generate revenue by the end of Q2 2025. The IPO closing press release (29 August 2025) instead listed the three divisions as the GrowHub Platform, product trading facilitation, and IT professional services. The 20-F notes that the Australian entity behind the Innovation Centre (GrowHub Innovation Centre Pty Ltd) was deregistered in December 2025. The Innovation Centre therefore appears to have been discontinued before it generated material revenue.
The 20-F risk factors state that the company was substantially dependent on the GrowHub Platform for revenue in FY2024 and FY2025. Revenue is project-based and comes from a small number of customers. Most revenue came from Singapore in both years.
Business model and revenue model
| Stream | Nature (analyst characterization) | Recognition |
|---|---|---|
| Professional service revenue | Project-based platform implementation and IT/software services for brand owners and agencies | Over time |
| Subscription revenue | SaaS access to the GrowHub Platform (traceability, anti-counterfeit, carbon modules) | Over time |
| Sales of goods | Trading of food, agricultural, skincare and other products through retail and online channels | Point in time |
| Consignment sales | Consignment of partner goods (only FY2024: S$1.8k) | Point in time |
Revenue is reported in four streams (FY2025 20-F, Note on Revenue):
FY2025 mix: professional services 30.8%, subscription 28.4%, sales of goods 40.8%. Subscription, the only recurring stream, was S$23.6k (about US$18.3k) in FY2025. This is too small to call the company a SaaS business in economic terms, despite how it positions itself.
Value-chain position
GrowHub positions itself in the "trust layer" between producers and brand owners on one side and retailers and consumers on the other. It records supply-chain events (origin, processing, logistics) as immutable entries on the Polygon public chain. Consumers access these through QR codes and NFC/RFID tags. The company is an application-layer provider: it does not own blockchain infrastructure and relies on Polygon, Google and Amazon Web Services for hosting (20-F risk factors). Its trading arm sits downstream as a distributor or facilitator of premium food products. This reflects the founder's original "farm-to-table" export-partner model described in 2023 press coverage.
Customer types and end-markets
- Brand owners and producers of premium food and agricultural goods. Named clients in 2023 press coverage included ManukaLife Honey, tangobar, Dirty Clean Food Oatmilk and Koufuku Granola (Asia Food Journal, 10 Mar 2023).
Government and quasi-government bodies: The company claims government collaborations in Japan, Bhutan and Australia (424B4). In September 2025 it signed a non-binding MoU with the Government of the Republic of Srpska (Bosnia and Herzegovina) covering ESG and traceability.
Carbon-project developers: (soil carbon and nature-based projects).
Regulated-industry and public-sector customers: These are cited generically in the risk factors.
Customer concentration is extreme. The largest customer was 66.4% of revenue in FY2022, 58.6% in FY2023 and 40.0% in FY2024. The top five were about 90% or more in each year.
Independent characterization
On the evidence of the audited accounts, GrowHub has not achieved product-market fit at commercial scale. Cumulative audited revenue across FY2023–FY2025 was S$448.6k. Cumulative net loss over the same period was S$21.4M, and the accumulated deficit reached S$23.9M at end-2025. In practice the business is a sub-scale, founder-funded technology and trading venture. Its main post-IPO strategic asset has been the Nasdaq listing itself, which the May–July 2026 EnChem transaction now seeks to repurpose. Investors should evaluate TGHL less as a traceability company and more as a pending reverse-merger vehicle. Its value depends on the merger closing, the post-merger Nasdaq listing approval, and EnChem America's economics.
Strategy
Stated strategy (pre-merger, from the 424B4)
The prospectus set out four growth strategies:
-
Expand geographically within Asia-Pacific over two years.
-
Invest in AI and data analytics.
-
Grow market share in Australia, Japan, Malaysia, Bhutan and other existing markets.
-
Establish a corporate venture capital arm.
Claimed competitive strengths were a one-stop traceability offering, government partnerships (Japan, Bhutan, Australia), a subscription SaaS model, early Web3-enabled traceability in APAC, and an experienced management team.
Stated uses of IPO proceeds were technology development, repayment of the related-party working-capital loan, expansion into new geographic markets, and working capital and general corporate purposes.
Execution against strategy (last 24 months)
| Initiative | Announced | Status at Oct 2026 | Assessment |
|---|---|---|---|
| GrowHub Innovation Centre (WA) | 2022–2025 | Entity deregistered Dec 2025 | Abandoned |
| Vietnam platform development | Entity acquired Feb 2025 | Deregistered Oct 2025 | Abandoned within about 8 months |
| Australia market expansion | IPO strategy | Australian entities deregistered | Reversed |
| Government partnerships: Republic of Srpska MoU (ESG, carbon monitoring, traceability) | 9 Sep 2025 | No revenue or project contracts disclosed | Non-binding; no measurable output |
| AI/data analytics investment | IPO strategy | No product disclosed; capex S$1.6k in FY2025 | No evidence of investment |
| Corporate venture capital | IPO strategy | No vehicle or investments disclosed | Not executed |
| Repay related-party loan | IPO use of proceeds | S$2.40M repaid in 2025; S$3.15M CEO loan outstanding | Partially executed |
| Reverse merger with EnChem America | Term sheet 28–29 May 2026; merger agreement 14 Jul 2026 | Pending; outside date 2 Dec 2026 | Strategic pivot that supersedes the original strategy |
| Capital restructuring (authorized capital to US$2.525M; reverse split up to 1:200) | EGM 5 Aug 2026 | Approved; split not yet effected as of research date | Enabler for merger and Nasdaq compliance |
Medium-term targets and guidance
The company has issued no financial guidance or medium-term targets. The merger documentation implies a post-merger funding plan:
-
At least a US$200M shelf registration once TGHL is F-3 eligible.
-
Per Korean press, EnChem intends to raise at least US$200M in U.S. capital through the listed vehicle after the merger, drawn in phases by capital call. Uses would include raw materials, working capital, operation of the Georgia plant and North American customer supply.
ESG and sustainability commitments
None quantified.
Products & Services
GrowHub Platform (core division)
| Attribute | Traceability module | Anti-counterfeit module | Carbon management module |
|---|---|---|---|
| Description | Records each supply-chain stage (origin farm, production method, transport route) as an immutable ledger entry on Polygon. Consumers view provenance by scanning a QR code through a web application. | Validates product authenticity using RFID and NFC tags at supply-chain checkpoints. Aimed at brands facing counterfeiting, revenue loss and reputational damage. | SaaS tool to track, monitor and measure carbon emissions or offsets. Initial use cases were soil-carbon markets; later positioned for nature-based projects such as reforestation (Srpska MoU). |
| Key capabilities | Public-chain anchoring; cloud transmission; consumer-facing provenance pages; analytics on consumer interactions | Tag-based verification at checkpoints; consumer verification | Emissions and offset tracking; carbon-credit tracing |
| Target customer | Premium food and agri brands; exporters; government agri bodies | Brand owners in food, skincare and premium goods | Carbon-project developers; corporates; governments |
| Launch / version | Operating since 2020–2021; no version history disclosed | — | Referenced from 2023 |
| Pricing model | Subscription (SaaS) plus implementation fees; price points not disclosed | — | — |
| FY2025 revenue | Not disclosed by module. Total subscription revenue S$23.6k; professional services S$25.6k. | — | — |
Sources: 424B4; FY2025 20-F; Quality Assurance & Food Safety magazine; Asia Food Journal.
The company claimed in its prospectus to be among few Asia-Pacific operators of a public-blockchain traceability system where data goes directly to the cloud and to public chain records. It also claimed an early position in Web3-enabled traceability.
Data analytics and AI tools
The IPO prospectus lists investment in AI and data analytics as a growth strategy, and the Srpska MoU (September 2025) lists "AI data analytics tools" and "digital asset solutions" among the company's offerings. No standalone product names, launch dates or revenue have been disclosed.
Product trading facilitation
The company trades in food, agricultural, skincare and other products and places partners' goods in retail outlets and online channels. It operated through GrowHub Capital (Singapore), GrowHub Malaysia, GrowHub Japan and, until December 2025, GrowHub Trading (Australia). Revenue: sales of goods S$33.9k in FY2025, plus S$1.8k consignment in FY2024. Inventory write-offs were S$172.3k in FY2023, S$0.1k in FY2024 and S$1.7k in FY2025. Year-end inventory went from S$50.5k (FY2024) to nil (FY2025), which suggests the trading activity was being run down.
IT professional services and software development
These are project-based services: software development, consultancy and platform implementation. They were the largest stream in FY2023–FY2024 (S$76.8k, then S$175.5k) before falling to S$25.6k in FY2025.
GrowHub Innovation Centre (discontinued)
This was a planned third division at the FIPWA hub in Western Australia, offering rental and auxiliary services and an innovation/data hub. The 424B4 projected revenue from end-Q2 2025. The operating entity was deregistered in December 2025, and right-of-use assets fell from S$201.6k to S$13.8k with a lease-termination loss recorded.
Blockchain services
Aggregator descriptions mention "blockchain services" and rental/auxiliary services. No separate revenue is disclosed beyond the four streams above.
Financial Narrative
Data availability: Audited full-year income statements and cash-flow statements are available for FY2023–FY2025 (FY2025 20-F). Balance sheets are available for 31 Dec 2024 and 31 Dec 2025. FY2022 is available only partially: net loss S$1.9M (F-1, Oct 2024) and opening equity. FY2021 was not disclosed in the materials reviewed. A 2023 press article cited an estimated FY2022 revenue of US$750k (company-sourced and unaudited). That figure cannot be reconciled with the audited series and is excluded from the tables.
Income statement, S$ thousands
Source: FY2025 20-F, Consolidated Statements of Operations (XBRL R4). EBITDA and gross profit are analyst-derived. FY2025 net loss = US$13.38M.
Sources: F-1 (Oct 2024) for FY2022; FY2025 20-F for FY2023–FY2025.
Revenue CAGR FY2023–FY2025: -19.6% per year (S$128.5k to S$83.0k). Analyst calculation.
Adjusted view. Other expenses in FY2025 include a non-cash intangible-asset write-off of S$1,990,000. This wrote off the full remaining carrying value of the intangible acquired under the 2020 asset purchase agreement, whose consideration was revised to S$1.99M in 2021. The FY2023 figure includes a S$142.5k write-off. Excluding write-offs, FY2025 EBITDA was about S$-14.89M and FY2023 about S$-1.52M. Analyst calculation.
Other expenses detail (S$ thousand):
Source: FY2025 20-F XBRL R67. The FY2023 components sum to S$458.8k against S$456.8k on the face of the income statement, a small discrepancy within the source.
Interim data point (unaudited, six months to 30 June):
Source: 6-K with interim financial statements (H1 2025).
Derived H2 2025: revenue about S$19.7k and net loss about S$15.36M. H1 2025 showed only S$0.86M of "other expenses" with no separate professional-fee line. Essentially all of the S$12.9M FY2025 professional fees were therefore booked in H2 2025, after the August 2025 IPO. The 20-F extracts reviewed do not itemize these fees. They are the single most important unexplained item in the accounts, and investors should obtain the full 20-F MD&A discussion of them.
Balance sheet, S$ thousands
Source: FY2025 20-F (XBRL R2). FY2025 in US$: total assets 1.02M; total liabilities 3.32M; deficit -2.30M; cash 0.91M.
Equity history: shareholders' deficit was S$-2,467k at end-2022, S$-2,660k at end-2023, S$-1,670k at end-2024 and S$-2,956k at end-2025 (20-F statement of changes in equity). The group has never had positive book equity in the audited periods presented, including after raising US$15M gross in the IPO. The negative US$2.30M equity at end-2025 triggered the Nasdaq equity deficiency notice.
Cash flow, S$ thousands
Source: FY2025 20-F (XBRL R6). Free cash flow is analyst-derived.
FY2025 operating cash burn (S$14.0M, about US$10.9M) absorbed roughly 83% of the S$16.8M net equity raised that year. The company ended the year with S$1.16M in cash against S$4.27M of liabilities due within twelve months.
Ratios
ROE, ROIC, net debt/EBITDA and the cash conversion cycle are not meaningful: equity is negative, invested capital is negative, and EBITDA is negative. FY2023 balance-sheet ratios cannot be computed because the 31 Dec 2023 balance sheet was not in the documents reviewed.
Commentary on trends, inflections and drivers
Revenue. Revenue rose 84% in FY2024 on one-off professional-services projects, then fell 65% in FY2025. Revenue appears to have nearly stopped in H2 2025: about S$19.7k derived for the half year. No evidence of a recurring revenue base has emerged. Year-end receivables collapsed from S$139k to under S$1k, consistent with near-zero activity at year-end.
Cost structure. The defining inflection is the jump in professional fees, from S$0.6M to S$12.9M, concentrated after the IPO. It was accompanied by a 75% rise in staff costs and the S$1.99M intangible write-off. The write-off removed almost all of the company's long-lived assets, which suggests management no longer regarded the originally acquired platform asset as recoverable.
Funding model. Before the IPO the group was funded by founder-family loans: the father's facility of up to S$6M and the founder's facility of up to S$8M, both at 3% and repayable on 60 days' demand. The IPO replaced part of this, and S$2.4M was repaid in 2025. A S$3.15M CEO loan remained outstanding at end-2025, classified as current. The continuing demand-loan dependence on the controlling shareholder is a key liquidity variable.
Liquidity. The FY2025 accounts show current liabilities exceeding current assets by S$3.04M (US$2.36M), together with recurring losses. The company's continued operation has depended on the controlling shareholder's forbearance on the demand loan and on the EnChem transaction. The 20-F extracts reviewed did not show the auditor's going-concern wording, so it is not characterized here.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue stream (SGD K)
| Revenue stream (SGD K) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Professional service revenue | 76.8 | 175.5 | 25.6 |
Subscription revenue | 4.3 | 21.7 | 23.6 |
Sales of goods | 47.4 | 38.0 | 33.9 |
Consignment sales | 0.0 | 1.8 | 0.0 |
Total revenue | 128.5 | 237.0 | 83.0 |
Share of total revenue (%)
| Share of total revenue (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Professional services | 59.8 | 74.1 | 30.8 |
Subscription | 3.3 | 9.2 | 28.4 |
Sales of goods | 36.9 | 16.0 | 40.8 |
Consignment | 0.0 | 0.8 | 0.0 |
YoY growth (%)
| YoY growth (%) | FY2024 | FY2025 |
|---|---|---|
Professional services | 128.5 | -85.4 |
Subscription | 406.8 | 8.5 |
Sales of goods | -19.9 | -10.8 |
Total revenue | 84.4 | -65.0 |
Revenue by Segment
| Recognition timing (SGD K) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Point in time | 47.4 | 39.8 | 33.9 |
Over time | 81.1 | 197.2 | 49.2 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansGroup Entities
| Entity | Jurisdiction | Incorporated | Principal activity | Status |
|---|---|---|---|---|
THE GROWHUB LIMITED | Cayman Islands | 12 Apr 2024 | Listed holding company | Active |
THE GROWHUB INNOVATIONS COMPANY LIMITED (GrowHub BVI) | BVI | 12 Apr 2024 | Investment holding | Active |
The GrowHub Innovations Company Pte. Ltd. | Singapore | 17 Aug 2020 | Investment holding | Active |
GrowHub Carbon Pte. Ltd. (fka GrowHub (Apac)) | Singapore | 6 Jan 2020 | Investment holding | Active |
GrowHub Capital Pte. Ltd. (fka GrowHub Distribution (Singapore)) | Singapore | 11 Feb 2020 | Agricultural product distribution | Active |
GrowHub Technologies Pte. Ltd. | Singapore | 23 Mar 2022 | Blockchain authentication, tracing and data services | Active |
GrowHub Malaysia Sdn. Bhd. | Malaysia | 28 Feb 2022 | Agricultural product distribution | Active |
GrowHub Japan Co., Ltd. | Japan | 30 Jul 2021 | Agricultural product distribution and trading | Active |
GrowHub Trading Pty Ltd | Australia | 3 Apr 2020 | Agricultural product trading | Deregistered Dec 2025 |
GrowHub Innovation Centre Pty Ltd | Australia | 17 Mar 2022 | Rental and auxiliary services (FIPWA hub) | Deregistered Dec 2025 |
GrowHub Vietnam LLC | Vietnam | 9 Oct 2024 | Blockchain platform development | Acquired Feb 2025 from a common director; deregistered Oct 2025 |
Income Statement
| Metric (SGD K) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Revenue | 128.5 | 237.0 | 83.0 |
Purchases and other direct costs | -110.5 | -166.7 | -99.5 |
Gross profit (revenue less direct costs) | 18.0 | 70.3 | -16.5 |
Inventory write-off | -172.3 | -0.1 | -1.7 |
Employee benefits expenses | -753.3 | -850.8 | -1,484.8 |
Professional fees | -235.6 | -621.6 | -12,912.0 |
Depreciation and amortization | -49.4 | -27.9 | -44.2 |
Operating lease expenses | -61.8 | -71.1 | -125.6 |
Other expenses | -456.8 | -809.0 | -2,339.0 |
Operating loss | -1,711.2 | -2,310.1 | -16,923.7 |
EBITDA (operating loss plus D&A) | -1,661.8 | -2,282.2 | -16,879.6 |
Interest expense | -119.7 | -159.5 | -90.8 |
Pre-tax loss | -1,793.4 | -2,367.6 | -17,200.8 |
Income tax (expense)/credit | -2.9 | 3.8 | 0.2 |
Net loss | -1,796.3 | -2,363.8 | -17,200.6 |
Net loss attributable to TGHL | -1,773.1 | -2,358.2 | -17,200.6 |
Key Financials
| Net loss, extended series (SGD Mn) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Net loss | -1.9 | -1.80 | -2.36 | -17.20 |
Per-share data
| Per-share data | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Basic and diluted EPS (SGD) | -0.08 | -0.11 | -0.75 |
Basic and diluted EPS (USD) | — | — | -0.59 |
Dividends per share (USD) | 0 | 0 | 0 |
Weighted average shares (million) | 21.55 | 21.55 | 22.83 |
Margins (%)
| Margins (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Gross margin | 14.0 | 29.7 | -19.9 |
Operating margin | -1,331.4 | -974.7 | -20,382.2 |
EBITDA margin | -1,292.9 | -962.9 | -20,328.9 |
Net margin | -1,397.6 | -997.3 | -20,715.6 |
Other expenses component (SGD K)
| Other expenses component (SGD K) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Marketing expenses | 66.6 | 28.2 | 15.2 |
Penalty | 58.4 | 4.3 | 4.6 |
Referral fee | 0.0 | 584.6 | 0.0 |
Intangible assets write-off | 142.5 | 0.0 | 1,990.0 |
Other | 191.3 | 191.8 | 329.2 |
Income Statement (Half-Yearly)
| H1 metric (SGD K) | H1 2024 | H1 2025 |
|---|---|---|
Revenue | 180.5 | 63.3 |
Employee benefits expenses | -281.7 | -779.6 |
Other expenses | -643.3 | -857.9 |
Operating loss | -836.2 | -1,721.1 |
Net loss | -784.0 | -1,844.6 |
Balance Sheet
| Balance sheet item (SGD K) | FY2024 | FY2025 |
|---|---|---|
Cash and cash equivalents | 546.3 | 1,163.9 |
Accounts receivable, net | 139.3 | 0.9 |
Inventories, net | 50.5 | 0.0 |
Deferred offering costs | 927.3 | 0.0 |
Other current assets | 322.7 | 69.5 |
Total current assets | 1,986.1 | 1,234.3 |
Intangible assets, net | 2,082.8 | 66.9 |
Plant and equipment, net | 20.8 | 0.4 |
Right-of-use assets | 201.6 | 13.8 |
Total assets | 4,291.4 | 1,315.4 |
Accounts payable | 19.8 | 0.2 |
Accruals and other current liabilities | 254.9 | 1,105.2 |
Working capital loan from related party | 5,475.5 | 3,151.7 |
Operating lease liabilities (total) | 210.7 | 14.1 |
Total liabilities | 5,961.5 | 4,271.7 |
Total shareholders' deficit | -1,670.2 | -2,956.3 |
Accumulated losses | -6,745.6 | -23,946.2 |
Additional paid-in capital | 5,021.9 | 20,698.5 |
Liquidity & Coverage Ratios
| Derived balance sheet metrics (SGD K) | FY2024 | FY2025 |
|---|---|---|
Total debt (related-party loan; all current) | 5,475.5 | 3,151.7 |
Long-term debt | 0.0 | 0.0 |
Net debt | 4,929.2 | 1,987.8 |
Working capital | -3,822.7 | -3,035.3 |
Goodwill and intangibles | 2,082.8 | 66.9 |
Cash flow item (SGD K)
| Cash flow item (SGD K) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Net cash used in operating activities | -1,141.7 | -3,288.9 | -14,041.0 |
Capital expenditure (PP&E plus intangibles) | -35.0 | -22.8 | -1.6 |
Free cash flow | -1,176.7 | -3,311.6 | -14,042.6 |
Proceeds from share issuance, net | 1,592.4 | 3,341.0 | 16,836.9 |
Related-party loan proceeds | 0.0 | 1,264.3 | 0.0 |
Related-party loan repayments | -312.4 | 0.0 | -2,401.8 |
Deferred offering costs paid | -105.6 | -751.7 | 0.0 |
Net cash from financing | 1,174.5 | 3,853.6 | 14,435.1 |
Dividends paid | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 |
Year-end cash | 15.0 | 546.3 | 1,163.9 |
Financial Ratios (x) and Returns & Leverage Ratios (%)
| Ratio | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Current ratio (x) | — | 0.34 | 0.29 |
Debt to equity (x) | — | -3.28 | -1.07 |
Interest coverage, operating loss / interest (x) | -14.3 | -14.5 | -186.4 |
Return on average assets (%) | — | — | -613.6 |
Asset turnover (x) | — | — | 0.03 |
Geographic Revenue
| Region | FY2024 | FY2025 | Commentary |
|---|---|---|---|
Singapore | — | — | Headquarters and principal customer base |
Malaysia | — | — | Distribution subsidiary (GrowHub Malaysia) |
Australia | — | — | Both Australian subsidiaries deregistered Dec 2025; expect nil going forward |
Japan | — | — | Trading subsidiary in Kansai region |
Vietnam | — | — | Entity acquired Feb 2025, deregistered Oct 2025 |
Americas / EMEA | Nil | Nil | Srpska MoU (EMEA) is non-revenue to date; EnChem merger would shift the group to the U.S. |
Revenue by Region (%)
| Customer concentration (% of revenue) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Largest customer | 66.4 | 58.6 | 40.0 | 51.1 |
Top five customers | 91.5 | 89.7 | 90.4 | — |
Share Price History
| Date | Price (USD) | Context | Source |
|---|---|---|---|
27 Aug 2025 | 4.00 | IPO price | Press release |
9 Sep 2025 | -27.5% on the day | Srpska MoU announcement | StockTitan |
Dec 2025 | Below 1.00 for 30 business days | Nasdaq bid-price notice | 20-F |
20 Mar 2026 | 0.32 | — | Seeking Alpha |
23 Jun 2026 | 0.45 (market cap US$11.1M) | Post-delisting determination | Benzinga |
Early Jul 2026 | 1.52 (+86.6% on the day; market cap US$15.3M) | Merger-related rally | Benzinga (page dated 4 Jul 2026) |
3 Sep 2026 | 0.8805 (market cap US$22.3M) | — | StockAnalysis |
~9 Oct 2026 | about 0.74 (market cap about US$18.7M) | — | Meyka |
Share price metric | Value | — | — |
Return since IPO (to about 9 Oct 2026) | -81.5% (analyst calculation, US$4.00 to about US$0.74) | — | — |
1-year return | Not computed: no verified price for Oct 2025 | — | — |
3-year / 5-year return | Not applicable (listed Aug 2025) | — | — |
52-week range | US$0.27–3.75 (StockAnalysis, Sep 2026) vs US$0.27–4.25 (Benzinga, Jun–Jul 2026); the sources conflict on the high | — | — |
Volatility | Average weekly movement about 23.8% (Simply Wall St) | — | — |
Valuation Multiples
| Multiple | TGHL | Comment |
|---|---|---|
Market capitalization (USD Mn) | 18.7 | 25.30M shares |
Enterprise value (USD Mn) | 20.3 | Plus related-party loan US$2.45M, less cash US$0.91M (31 Dec 2025 balances) |
EV/Sales (x) | 314 | On FY2025 revenue US$64.6k |
P/Sales (x) | 290 | — |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None. No sell-side coverage identified. |
Dividend history and policy | Never paid; the 20-F states no plans for the foreseeable future, and Cayman law restricts distributions |
Credit ratings (Moody's, S&P, Fitch) | Not rated |
Debt maturity profile | Related-party loan of S$3.15M (US$2.45M), unsecured, 3% p.a., repayable within 60 days of demand; operating leases of S$14.1k. No bank or public debt. |
Warrants | 375,000 underwriter warrants at US$5.00; expire 27 Aug 2030 |
Authorized capital (post-Aug 2026) | 5,000,000,000 Class A and 50,000,000 Class B (US$2.525M) |
Approved reverse split | Up to 1:200, at board discretion within 12 months of 5 Aug 2026 |
Shares outstanding (million) | FY2023 |
Class A | 11.12 |
Class B | 10.43 |
Total | 21.55 |
Analyst Conclusions
Management guidance and consensus
No financial guidance has been issued and there is no consensus. The only forward-looking corporate commitments are the merger milestones: an EGM to approve the merger, SEC registration, Nasdaq approval, Class B conversion, and closing by 2 Dec 2026.
Bull case
-
The merger closes and the listing is preserved. TGHL becomes the U.S.-listed home of EnChem America, valued at US$379.7–428.3M by an independent evaluator. At the agreed terms, legacy holders' 15% implies about US$70.6M against a US$19–22M market cap.
-
Funded U.S. ESS growth story. EnChem plans a US$200M+ U.S. raise and has an existing Georgia plant. It has been selected as an LFP electrolyte supplier to North American ESS lines and targets more than 8,000 tons of North American ESS shipments in 2026.
-
Governance reset. Closing eliminates super-voting Class B shares, replaces the board and management with EnChem designees (at least three independent directors), and ends reliance on founder demand loans.
Bear case
-
Deal or listing failure. The Panel exception and merger outside date coincide on 2 Dec 2026. The term-sheet US$4.00 VWAP floor, the SEC registration timetable and the need to meet initial listing standards are all binding constraints. If the deal fails, TGHL is a company with S$83k revenue, negative equity and a demand loan from its controlling shareholder.
-
Legacy business has no standalone value. Revenue fell 65%, intangibles were fully written off, Australia and Vietnam were exited, and FY2025 operating cash burn was S$14.0M against year-end cash of S$1.16M.
-
Dilution and capital-structure overhang. Holders face about 85% merger dilution, authorized capital of 5bn shares, a reverse split of up to 1:200, and a US$200M shelf plus planned capital calls. Post-closing value per legacy share could be diluted further by financing at depressed prices.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | Why it matters |
|---|---|---|
| Filing and SEC effectiveness of merger registration statement (F-1/F-4) | Q4 2026 | Gating item for closing; will disclose EnChem America's audited financials for the first time |
| Board decision on reverse-split ratio and effective date | By Aug 2027 (12-month window); likely before closing | Required for US$1 bid price and Nasdaq initial listing standards |
| EGM to approve the merger | Q4 2026 | Controlling-shareholder voting agreement makes approval highly likely |
| Nasdaq approval of merger-share listing and Panel compliance determination | By 2 Dec 2026 | Binary listing outcome |
| Merger closing or termination | By 2 Dec 2026 outside date | Determines the company's identity |
| CFO succession | Ongoing | Financial reporting continuity |
| H1 2026 interim results (6-K) | By end-2026 under FPI timing | Cash runway and the professional-fee trajectory |
| Resolution of the S$3.15M CEO demand loan | At or before closing | Liquidity and related-party exposure |
| Post-merger US$200M shelf and first capital call | 2,027 | Funding of the Georgia plant; dilution |
| EnChem ESS volumes (North America) | 2026–2027 | Fundamental value driver of the post-merger entity |
Analyst verdict
The GrowHub Limited, as it has operated to date, is not an investable operating business. It is a listing in transition. Over FY2023–FY2025 the traceability-and-trading model produced S$448.6k of cumulative revenue against S$21.4M of cumulative net losses. Its only growing revenue line, subscriptions, reached just S$23.6k. Within four months of a US$15M IPO, the company booked S$12.9M of professional fees and wrote off its S$1.99M platform intangible. It exited Australia and Vietnam and ended FY2025 with negative equity of US$2.30M and a US$2.45M demand loan from its founder. Internal-control material weaknesses, an auditor change, a late annual report, a CFO resignation and boilerplate inconsistencies in the 20-F all point to thin governance and financial-reporting infrastructure.
The investment case therefore rests almost entirely on the EnChem America reverse merger. On paper the terms are generous to legacy holders: a 15% stake in a business independently valued at about US$380–428M implies roughly 3.5x the current market capitalization. The discount reflects real, binary risks. Nasdaq requires the combined company to meet initial listing standards by 2 Dec 2026, the same date as the merger's outside date. An SEC registration statement must become effective within weeks. The term sheet included a US$4.00 VWAP floor that the stock has not approached since its debut month. EnChem America's own audited financials have not yet been published, so the quality of the asset being injected cannot be independently assessed.
Verdict: a high-risk special situation, not a fundamental holding. Any position is a bet on deal completion, sized for possible total loss. The decisive monitorables are the merger registration filing, which will contain EnChem America's audited financials; the reverse-split execution; and Nasdaq's compliance determination by 2 December 2026. If the deal fails, the standalone business offers no credible path to solvency without continued founder support.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Source |
|---|---|---|---|---|
Chan Choon Yew Lester | Founder, Chairman, CEO, Director; Controlling Shareholder | Founder of operating group 2020; holdco Chairman/CEO since 2024 | Former CEO, Fund Singapore Pte Ltd (2016–2022); former Director, Beaconrock Consultancy Pte Ltd (2009–2016). Undergraduate degree, National University of Singapore; MBA, Singapore Management University. | 20-F; Zonebourse/MarketScreener insider profile |
Poh Chit Wen | Chief Financial Officer | Listed as CFO on 20-F cover (May 2026); Form 3 filed Apr 2026 | Resigned 31 Jul 2026 for personal reasons; effective date to be agreed. | 20-F; 6-K 4 Aug 2026 |
Alec Ngo | Chief Operating Officer (as of the platform launch coverage) | — | — | Quality Assurance & Food Safety magazine |
Chai Chun Kiat | CTO (appointment announced Mar 2023) | — | — | Asia Food Journal, Mar 2023 |
Aaron Loo Jian Lin | Chief Innovation Officer (appointment announced Mar 2023) | — | — | Asia Food Journal, Mar 2023 |
Board of Directors
| Name | Role | Independence | Committees | Background | Source |
|---|---|---|---|---|---|
Chan Choon Yew Lester | Chairman and CEO | Executive; controlling shareholder | — | See above | 20-F |
Jiao Jie | Director | Independent | Audit (Chair); Compensation; Nominating & Corporate Governance | — | 6-K Feb 2026 |
Yam Yuet Hang | Director | Independent | Compensation (Chair); Audit; Nominating & Corporate Governance | — | 6-K Feb 2026 |
Liu Wing Ki | Director (appointed 14 Feb 2026) | Independent (committee member) | Nominating & Corporate Governance (Chair); Audit; Compensation | VP, Sing Hoi International Holding (since 2023), overseeing finances; finance/accounting at Healthlase Medical Skin Centre (2019–2020); BA (Hons) Accountancy, University of Portsmouth (2010) | 6-K Feb 2026 |
Kim Ji Yeon | Director (appointed 14 Feb 2026) | Independent (committee member) | Audit; Compensation; Nominating & Corporate Governance | CEO, Duble J Company (Nov 2024–Dec 2025); strategy and promotion, CJ ENM (2023–2024); brand and content strategy for tvN and tvN Story (2011–2023); media and communications degree, Yonsei University (2004) | 6-K Feb 2026 |
Tan Kim Han Raymond | Former independent director | Independent | — | Resigned effective 13 Feb 2026 for personal reasons; no disagreement disclosed | 6-K Feb 2026 |
Major Shareholders
| Holder | Shares | Economic stake (%) | Voting power (%) | Source |
|---|---|---|---|---|
Chan Choon Yew Lester, via Initium Novum Capital, Vita Nova Ventures and EMJ Capital Holdings | 10,433,340 Class B | 41.2 | about 87.53 | 20-F; Form 3, Apr 2026 |
Other Class A holders, including pre-IPO investors and IPO and resale shareholders | 14,866,470 Class A | 58.8 | about 12.47 | 20-F |
Alexander Capital, L.P. (underwriter warrant) | Warrant over 375,000 Class A at US$5.00; exercisable from 24 Feb 2026 to 27 Aug 2030 | — | — | 20-F equity note |
Competitive Landscape
Key Competitors
| Competitor | Segment | Positioning vs TGHL |
|---|---|---|
TE-FOOD | Blockchain food traceability (SE Asia, Africa) | Direct APAC peer, also public-chain-based |
OriginTrail / Trace Labs | Decentralized knowledge graph for supply-chain data | Larger developer ecosystem |
Provenance (UK) | Product transparency and claims verification for consumer brands | Similar consumer-facing proposition with a stronger brand roster |
Sourcemap (US) | Supply-chain mapping and traceability for enterprises | Enterprise-grade, regulatory compliance focus (e.g., EUDR) |
Wholechain (US) | Food traceability (FSMA 204 compliance) | U.S. regulatory tailwind |
Trustwell (formerly FoodLogiQ) | Food safety and traceability SaaS | Established enterprise customer base |
Avery Dennison (atma.io connected product cloud) | Item-level digital identity (RFID/NFC) | Global scale; integrated tags plus software |
SGS | Testing, inspection, certification, traceability services | Incumbent trust provider |
Bureau Veritas | TIC plus traceability and origin verification | Incumbent trust provider |
OpSec Security; Authentix | Brand protection and anti-counterfeit | Specialist anti-counterfeit incumbents |
Sylvera; Pachama | Carbon-credit ratings and MRV | Specialist carbon MRV |
Competitor Detail
| Metric | TGHL (FY2025) |
|---|---|
Revenue | S$83.0k (US$64.6k) |
Revenue growth | -65.0% |
Operating margin | -20,382% |
Recent Developments
No interim H1 2026 financial statements were located as of the research date.



